Hispanic Broadcasting

Hispanic Broadcasting Newswire

Comprehensive Real-Time News Feed for Hispanic Broadcasting.

Results 1 - 20 of 186 in Hispanic Broadcasting

  1. Superconductor Technologies, Inc. (SCON), Pfizer Inc. (PFE), ACADIA...Read the original story w/Photo

    Wednesday | Insider Monkey

    Hal Mintz 's Sabby Capital has initiated a passive stake in Superconductor Technologies, Inc. according to a schedule 13G form filed with the SEC. The new holding contains 1.50 million shares and represents 8.24% of the company's outstanding common stock.

    Comment?

  2. 4 Top-Ranked Healthcare ETFs For A Healthy PortfolioRead the original story w/Photo

    Wednesday | Seeking Alpha

    After an incredible 2014, the healthcare sector is crushing the overall market this year too. This is largely owing to the bullish trend in both the pharma and biotech segments from strong earnings growth, a merger and acquisition frenzy and encouraging industry trends.

    Comment?

  3. Pfenex Announces Early HSR Clearance For Collaboration With HospiraRead the original story

    Sunday Mar 22 | BioSpace

    With the early termination of the applicable waiting period under the HSR Act, the collaboration agreement with Hospira is effective as of initial payment under the collaboration agreement is due to the company on or before the fifth business day following HSR clearance. Additional details regarding the collaboration can be found in Pfenex's Form 8-K filed with the Securities and Exchange Commission on Pfenex has used, and intends to continue to use, its Investor Relations website , as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

    Comment?

  4. Why drug names are so increasingly weirdRead the original story w/Photo

    Friday Mar 20 | Chicago Tribune

    With thousands of drugs on the market, the No. 1 reason drug names are rejected by the Food and Drug Administration is that the agency doesn't want names to be too similar when prescriptions are filled, said Brannon Cashion, global president of branding firm Addison Whitney.

    Comment?

  5. How newest class of drugs could save billions of dollarsRead the original story w/Photo

    Friday Mar 20 | Chicago Tribune

    Clad in white lab coats, blue gloves and safety goggles, scientists are buzzing around a lab at Hospira in Lake Forest. One lifts a clear vial to eye level as he uses a syringe to fill it with a clear solution.

    Comment?

  6. Pfizer In The Process Of Making Path Breaking VaccineRead the original story w/Photo

    Wednesday Mar 18 | GuruFocus.com

    When it comes to investment in pharma stocks, Pfizer Inc. appears to be the hot favorite with investors and analysts across the board. The reason being the sheer magnitude of its global business as well as good stock performance.

    Comment?

  7. Pfenex Reports Fourth Quarter And Full Year 2014 Results And Provides Business UpdateRead the original story

    Sunday Mar 15 | BioSpace

    "2015 is off to an exciting start, with our announcement of the collaboration with Hospira for our lead compound, PF582, a biosimilar candidate to Lucentis on in milestone payments along with tiered double digit royalties. This collaboration further validates the development strength and capability of Pfenex as we advance our pipeline.

    Comment?

  8. "Death of the death penalty by lethal injection shortage?"Read the original story

    Saturday Mar 14 | Sentencing Law and Policy

    The question in the title of this post is the headline of this notable recent Chicago Tribune column . Here is how it starts: A reliable supply line is crucial to any business.

    Comment?

  9. Death of the death penalty by lethal injection shortage?Read the original story w/Photo

    Friday Mar 13 | Chicago Tribune

    Oklahoma Department of Corrections officials inspect the renovated death chamber at the state penitentiary in McAlester on Oct. 9, 2014. State officials are considering the use of nitrogen gas to execute death row inmates.

    Comment?

  10. Berko: Abbott Labs has been fine investmentRead the original story w/Photo

    Saturday Mar 14 | The Columbian

    Dear Mr. Berko: My stockbroker is advising me to sell my 400 shares of AbbVie Inc., which was a 2013 spinoff of Abbott Laboratories. I inherited 400 shares of Abbott Labs when my daddy passed in 2002.

    Comment?

  11. Pfizer: Pharmacyclics Missed The OpportunityRead the original story w/Photo

    Friday Mar 13 | Seeking Alpha

    I'm not disparaging the recent deal Pharmacyclics made to be acquired by AbbVie for a 39% premium . As a Pfizer shareholder, I simply would've preferred for Pfizer to win that bidding war and take a major step in the cancer drug space.

    Comment?

  12. CVS: Copycat drugs may bring price cuts of 40-50%Read the original story w/Photo

    Thursday Mar 12 | MSN Money

    The entry of copycat biotech drugs into the U.S. market could cut prices of expensive medications by 40 percent to 50 percent, depending on the level of competition among drugmakers, a top executive at CVS Health told Reuters. CVS is one of the largest U.S. pharmacy benefit managers and, along with rival Express Scripts , has put unprecedented pressure on global pharmaceutical makers to lower prices for its clients.

    Comment?

  13. Exclusive: CVS says biotech drug copies may bring price cuts of 40-50 percentRead the original story

    Wednesday Mar 11 | WNFL-AM Green Bay

    The entry of copycat biotech drugs into the U.S. market could cut prices of expensive medications by 40 percent to 50 percent, depending on the level of competition among drugmakers, a top executive at CVS Health Corp told Reuters. CVS is one of the largest U.S. pharmacy benefit managers and, along with rival Express Scripts, has put unprecedented pressure on global pharmaceutical makers to lower prices for its clients.

    Comment?

  14. Hospira Issues a Voluntary Nationwide Recall of One Lot of Lactated...Read the original story

    Wednesday Mar 11 | US Food and Drug Administration

    March 11, 2015 - LAKE FOREST, Ill. - Hospira, Inc. , announced today it is initiating a voluntary recall of one lot of Lactated Ringer's Irrigation, 3000mL to the user level due to a confirmed customer report of several dark, fibrous particulates floating within the solution of the primary container.

    Comment?

  15. FDA approves knockoff of Amgen's Neupogen chemo recovery drugRead the original story w/Photo

    Friday Mar 6 | Los Angeles Times

    Amgen decided to enter biosimilars several years ago. "It was a natural extension of our biologic capability," said Vice President Richard Markus.

    Comment?

  16. Valeant Pharmaceuticals Remains A Risky BetRead the original story w/Photo

    Friday Mar 6 | Seeking Alpha

    The all-cash transaction will be funded through bank debt and bonds, increasing Valeant's net leverage ratio to 5.6. With interest rate hike imminent, Valeant's strategy of keeping a high net leverage ratio to fund growth carries significant risk. The last week was an eventful week for Valeant Pharmaceuticals International, Inc. , which was locked in a bitter takeover battle with Botox-maker Allergan Inc. last year.

    Comment?

  17. Amgen's portfolio threatened as FDA paves path for lower-cost drugsRead the original story w/Photo

    Friday Mar 6 | Pacific Business Times

    Zarxio, the first biopharmaceutical copycat approved in the U.S., will pave the way for lower-cost alternatives to existing treatments. The U.S. Food and Drug Administration today approved its first-ever biosimilar, a drug known as Zarxio that mimics Amgen's chemotherapy drug Neupogen, placing the Thousand Oaks-based biotech giant under peaked pressure to bring new treatments to market.

    Comment?

  18. Select to View Firm Press ReleaseRead the original story

    Friday Mar 6 | US Food and Drug Administration

    March 6, 2015 - LAKE FOREST, Ill. - Hospira, Inc., has announced a voluntary recall of one lot of Magnesium Sulfate in 5% Dextrose, Inj., USP, 10 mg/mL to the user level due to confirmed customer reports of an incorrect barcode on the primary bag labeling.

    Comment?

  19. Hospira Statement on FDA Approval of the First Biosimilar in the United StatesRead the original story

    Friday Mar 6 | Freshnews

    Hospira, Inc. , applauds Sandoz and the U.S. Food and Drug Administration on today's FDA approval of the first biosimilar in the United States. This is a watershed moment for improving patient access to safe, effective and more affordable biologic medicines.

    Comment?

  20. Hospira's Magnesium Injection Lot 42-120-JT May Have Barcode for HeparinRead the original story

    Friday Mar 6 | ASHP

    Hospira Inc. today announced it is recalling lot 42-120-JT of magnesium sulfate in 5% dextrose injection because the barcode on the bags may actually be the machine-readable code for 1000-mL bags of heparin sodium 2 units/mL. The company said the barcode on the magnesium bags' overwrap is correct.

    Comment?